Begin with program scope, not a dashboard
CDC organizes nursing-home antibiotic stewardship around seven connected elements. It specifically identifies access to consultant pharmacists or others with stewardship expertise under drug expertise.
A utilization chart can reveal a question, but it cannot establish appropriate therapy or a complete program. A small facility can begin with one defined action and one measure while keeping resident-specific clinical decisions with the responsible care team.
Choose the review question before extracting data
A bounded question prevents the first worklist from becoming an unreviewable inventory. The facility might select new starts, prolonged courses, records without a visible indication, or one syndrome already within its stewardship plan. The choice should be documented with the responsible program leaders so the consultant's review supports, rather than substitutes for, facility accountability.
Define the population, time window, data source, and expected decision before running the list. If those elements change mid-cycle, label the change. Otherwise a movement in count may reflect a different query rather than a different prescribing or resident-care pattern.
Define the smallest useful worklist
Choose a bounded review such as new antibiotic starts, prolonged courses, missing indications, or a facility-selected syndrome. For each item, identify the question, recipient, disposition, and follow-up date.
Pair the worklist with an agreed process and outcome measure. Keep the definitions stable long enough to learn; a moving denominator makes improvement hard to interpret.
Keep the resident record behind the aggregate
The aggregate measure can show where to look, but each work item needs enough context for an authorized reviewer to understand the question. Do not let a utilization flag become a clinical conclusion or an instruction to change therapy. The responsible clinician needs the resident record and current circumstances.
- Scope: why the item met the facility's defined review rule.
- Source: which medication and clinical records were available, with their dates.
- Question: the specific issue raised without prescribing an automatic answer.
- Route: the responsible recipient and the communication path used.
- Disposition: response, rationale when supplied, and any authorized action.
- Follow-up: an owner and date for unresolved or time-bound work.
Close the reporting loop
CDC includes regular feedback to prescribers, nursing staff, and other relevant staff. Decide who receives the report, who explains it, and what decision the group can make from it.
Software may help with extraction and trends, but the facility's program still needs leadership, clinical judgment, policies, and education. Describe the tool as support for that program, not proof that the program is complete.
Keep process and outcome measures in their lanes
CDC calls for tracking at least one measure of antibiotic use and at least one outcome from antibiotic use. Name both measures and their definitions before presenting them together. A process count may show whether a review or documentation step occurred; it does not, by itself, establish a resident outcome.
Use the measures to ask whether the agreed work is happening and whether the program needs closer review. Preserve alternative explanations when a value changes, including data timing or definition changes. Resident-level clinical interpretation still belongs with the responsible care team.
Test what the software can show—and what it cannot
Ask the system to reproduce one bounded worklist from named inputs, then trace a sample item back to its source. Include a missing indication, a late response, and a corrected record so the team can see how exceptions remain visible. Export the underlying records behind any trend chart.
That demonstration can show extraction, routing, follow-up, and traceability. It cannot prove that the facility has implemented all seven elements, that a particular antibiotic decision is appropriate, or that a reported movement was caused by the pharmacist's work. Keep those limits in the final report.